Induced Pluripotent Stem Cell-Derived Cardiomyocytes as a Model for Drug Cardiotoxicity Screening. Annals of Stem Cell Research, [S. l.], v. 6, n. 1, p. 1–6, 2023. DOI: 10.5281/zenodo.22237966. Disponível em: https://somatopub.com/index.php/ASCR/article/view/353. Acesso em: 31 oct. 2026.